Global and Regional Flow Cytometry research
Global and Regional Flow Cytometry research

Flow Cytometry Comprehensive Study by Type (Cytometry Platforms (Sorters, Analyzers), Replaceable Components (Filter, Laser, Detectors, Others), Accessories, Reagents and Consumables (Antibodies, Dyes, Beads, Solutions, Buffers, Others), Software, Services), Application (Academic and Clinical Research (Cell Cycle Analysis and Cell Proliferation, Apoptosis, Sorting and Screening, Transfection and Cell Viability, Others), Diagnosis (Organ Transplantation, Hematological Malignancies, Cancer and Solid Tumors, Immunodeficiency Diseases- HIV Infection, Others)), Technology (Cell-Based, Bead-Based), End User (Commercial Organizations, Medical Schools and Clinical Labs, Hospitals, Academics, Others) Players and Region - Global Market Outlook to 2024

Flow Cytometry Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024 | CAGR: 9.3%  

May 2019 Edition 217 Pages 164 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study
Growth in the use of flow cytometry in stem cell research will help to boost the global flow cytometry market. Flow cytometry is a method used to identify and measure the physical and chemical features of a population of cells or particles. Additionally, it is used in cell counting, cell sorting, detecting biomarker, and protein engineering. There is a large void in diagnostics accessibility, particularly in the developing regions. So, the growing incidences of HIV AIDS and cancer can be measured a substantial growth opportunity for the global flow cytometry market.

The market study is being classified by Type (Cytometry Platforms [Sorters, Analyzers], Replaceable Components [Filter, Laser, Detectors, Others], Accessories, Reagents and Consumables [Antibodies, Dyes, Beads, Solutions, Buffers, Others], Software and Services), by Application (Academic and Clinical Research [Cell Cycle Analysis and Cell Proliferation, Apoptosis, Sorting and Screening, Transfection and Cell Viability, Others] and Diagnosis [Organ Transplantation, Hematological Malignancies, Cancer and Solid Tumors, Immunodeficiency Diseases- HIV Infection, Others]) and major geographies with country level break-up. According to AMA, the Global Flow Cytometry market is expected to see growth rate of 9.3%

Becton, Dickinson and Company (United States), Thermo Fisher Scientific, Inc. (United States), Beckman Coulter, Inc. (United States), Merck KGaA (Germany), Luminex Corporation (United States), Sysmex Partec GmbH (Germany), Miltenyi Biotec GmbH (Germany), Agilent Technologies, Inc. (United States), bioMérieux S.A. (France) and Bio-Rad Laboratories, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Sony Biotechnology, Inc. (United States), Enzo Life Sciences, Inc. (United States), Stratedigm, Inc. (United States), Cytonome/ST LLC (United States) and Apogee Flow Systems Ltd. (United Kingdom).

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Flow Cytometry market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Flow Cytometry market by Type, Application and Region.

On the basis of geography, the market of Flow Cytometry has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Technology, the sub-segment i.e. Cell-Based will boost the Flow Cytometry market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Commercial Organizations will boost the Flow Cytometry market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growing Prevalence of Cancer and HIV/AIDS
  • Upsurge in the Applications of Flow Cytometry in Clinical Research
  • Increasing Adoption of Flow Cytometry Techniques in Research and Academia

Market Trend
  • The Emergence and Commercial Application of New Technologies in the Field Of Flow Cytometry
  • Intensifying Stem Cell Research
  • Developing Public-Private Initiatives in the Field Of Immunology and Immuno-Oncology Researches

Restraints
  • Lack of Skilled Professionals
  • The Lack of Proper Knowledge

Opportunities
  • Growing Availability of Novel Application-Specific Flow Cytometry Products
  • Increasing Market Presence in Emerging Countries
  • Adoption of Recombinant DNA Technology for Antibody Production

Challenges
  • Inadequate Research Infrastructure across Emerging Countries
  • Complexities Related To Reagent Development


Market Leaders and their expansionary development strategies
On 26th March 2019, BD (Becton, Dickinson and Company), a leading global medical technology company has announced the CE-IVD certification for the BD FACSDuet™ automated flow cytometry system. It allows clinical laboratories to expand their efficiency by dropping errors and restraining the manual user interactions required to run assays on the BD FACSLyric™ clinical flow cytometer.
On 18th October 2018, Luminex has acquired MilliporeSigma's flow cytometry portfolio. The deal is established for 75 million dollars, consisting of about 69.9 million dollars to be paid under a stock and asset purchase agreement and about 5.1 million dollars in committed inventory purchases.


Key Target Audience
Government Regulatory Bodies, Government and Private Research Organizations and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Cytometry Platforms [Sorters, Analyzers]
  • Replaceable Components [Filter, Laser, Detectors, Others]
  • Accessories
  • Reagents and Consumables [Antibodies, Dyes, Beads, Solutions, Buffers, Others]
  • Software
  • Services
By Application
  • Academic and Clinical Research [Cell Cycle Analysis and Cell Proliferation, Apoptosis, Sorting and Screening, Transfection and Cell Viability, Others]
  • Diagnosis [Organ Transplantation, Hematological Malignancies, Cancer and Solid Tumors, Immunodeficiency Diseases- HIV Infection, Others]
By Technology
  • Cell-Based
  • Bead-Based

By End User
  • Commercial Organizations
  • Medical Schools and Clinical Labs
  • Hospitals
  • Academics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Prevalence of Cancer and HIV/AIDS
      • 3.2.2. Upsurge in the Applications of Flow Cytometry in Clinical Research
      • 3.2.3. Increasing Adoption of Flow Cytometry Techniques in Research and Academia
    • 3.3. Market Challenges
      • 3.3.1. Inadequate Research Infrastructure across Emerging Countries
      • 3.3.2. Complexities Related To Reagent Development
    • 3.4. Market Trends
      • 3.4.1. The Emergence and Commercial Application of New Technologies in the Field Of Flow Cytometry
      • 3.4.2. Intensifying Stem Cell Research
      • 3.4.3. Developing Public-Private Initiatives in the Field Of Immunology and Immuno-Oncology Researches
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Flow Cytometry, by Type, Application, Technology, End User and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Flow Cytometry (Value)
      • 5.2.1. Global Flow Cytometry by: Type (Value)
        • 5.2.1.1. Cytometry Platforms [Sorters, Analyzers]
        • 5.2.1.2. Replaceable Components [Filter, Laser, Detectors, Others]
        • 5.2.1.3. Accessories
        • 5.2.1.4. Reagents and Consumables [Antibodies, Dyes, Beads, Solutions, Buffers, Others]
        • 5.2.1.5. Software
        • 5.2.1.6. Services
      • 5.2.2. Global Flow Cytometry by: Application (Value)
        • 5.2.2.1. Academic and Clinical Research [Cell Cycle Analysis and Cell Proliferation, Apoptosis, Sorting and Screening, Transfection and Cell Viability, Others]
        • 5.2.2.2. Diagnosis [Organ Transplantation, Hematological Malignancies, Cancer and Solid Tumors, Immunodeficiency Diseases- HIV Infection, Others]
      • 5.2.3. Global Flow Cytometry by: Technology (Value)
        • 5.2.3.1. Cell-Based
        • 5.2.3.2. Bead-Based
      • 5.2.4. Global Flow Cytometry by: End User (Value)
        • 5.2.4.1. Commercial Organizations
        • 5.2.4.2. Medical Schools and Clinical Labs
        • 5.2.4.3. Hospitals
        • 5.2.4.4. Academics
        • 5.2.4.5. Others
      • 5.2.5. Global Flow Cytometry Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Flow Cytometry: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton, Dickinson and Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Beckman Coulter, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck KGaA (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Luminex Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sysmex Partec GmbH (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Miltenyi Biotec GmbH (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Agilent Technologies, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. BioMérieux S.A. (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Flow Cytometry Sale, by Type, Application, Technology, End User and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Flow Cytometry (Value)
      • 7.2.1. Global Flow Cytometry by: Type (Value)
        • 7.2.1.1. Cytometry Platforms [Sorters, Analyzers]
        • 7.2.1.2. Replaceable Components [Filter, Laser, Detectors, Others]
        • 7.2.1.3. Accessories
        • 7.2.1.4. Reagents and Consumables [Antibodies, Dyes, Beads, Solutions, Buffers, Others]
        • 7.2.1.5. Software
        • 7.2.1.6. Services
      • 7.2.2. Global Flow Cytometry by: Application (Value)
        • 7.2.2.1. Academic and Clinical Research [Cell Cycle Analysis and Cell Proliferation, Apoptosis, Sorting and Screening, Transfection and Cell Viability, Others]
        • 7.2.2.2. Diagnosis [Organ Transplantation, Hematological Malignancies, Cancer and Solid Tumors, Immunodeficiency Diseases- HIV Infection, Others]
      • 7.2.3. Global Flow Cytometry by: Technology (Value)
        • 7.2.3.1. Cell-Based
        • 7.2.3.2. Bead-Based
      • 7.2.4. Global Flow Cytometry by: End User (Value)
        • 7.2.4.1. Commercial Organizations
        • 7.2.4.2. Medical Schools and Clinical Labs
        • 7.2.4.3. Hospitals
        • 7.2.4.4. Academics
        • 7.2.4.5. Others
      • 7.2.5. Global Flow Cytometry Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Flow Cytometry: by Type(USD Million)
  • Table 2. Flow Cytometry Cytometry Platforms [Sorters, Analyzers] , by Region USD Million (2013-2018)
  • Table 3. Flow Cytometry Replaceable Components [Filter, Laser, Detectors, Others] , by Region USD Million (2013-2018)
  • Table 4. Flow Cytometry Accessories , by Region USD Million (2013-2018)
  • Table 5. Flow Cytometry Reagents and Consumables [Antibodies, Dyes, Beads, Solutions, Buffers, Others] , by Region USD Million (2013-2018)
  • Table 6. Flow Cytometry Software , by Region USD Million (2013-2018)
  • Table 7. Flow Cytometry Services , by Region USD Million (2013-2018)
  • Table 8. Flow Cytometry: by Application(USD Million)
  • Table 9. Flow Cytometry Academic and Clinical Research [Cell Cycle Analysis and Cell Proliferation, Apoptosis, Sorting and Screening, Transfection and Cell Viability, Others] , by Region USD Million (2013-2018)
  • Table 10. Flow Cytometry Diagnosis [Organ Transplantation, Hematological Malignancies, Cancer and Solid Tumors, Immunodeficiency Diseases- HIV Infection, Others] , by Region USD Million (2013-2018)
  • Table 11. Flow Cytometry: by Technology(USD Million)
  • Table 12. Flow Cytometry Cell-Based , by Region USD Million (2013-2018)
  • Table 13. Flow Cytometry Bead-Based , by Region USD Million (2013-2018)
  • Table 14. Flow Cytometry: by End User(USD Million)
  • Table 15. Flow Cytometry Commercial Organizations , by Region USD Million (2013-2018)
  • Table 16. Flow Cytometry Medical Schools and Clinical Labs , by Region USD Million (2013-2018)
  • Table 17. Flow Cytometry Hospitals , by Region USD Million (2013-2018)
  • Table 18. Flow Cytometry Academics , by Region USD Million (2013-2018)
  • Table 19. Flow Cytometry Others , by Region USD Million (2013-2018)
  • Table 20. South America Flow Cytometry, by Country USD Million (2013-2018)
  • Table 21. South America Flow Cytometry, by Type USD Million (2013-2018)
  • Table 22. South America Flow Cytometry, by Application USD Million (2013-2018)
  • Table 23. South America Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 24. South America Flow Cytometry, by End User USD Million (2013-2018)
  • Table 25. Brazil Flow Cytometry, by Type USD Million (2013-2018)
  • Table 26. Brazil Flow Cytometry, by Application USD Million (2013-2018)
  • Table 27. Brazil Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 28. Brazil Flow Cytometry, by End User USD Million (2013-2018)
  • Table 29. Argentina Flow Cytometry, by Type USD Million (2013-2018)
  • Table 30. Argentina Flow Cytometry, by Application USD Million (2013-2018)
  • Table 31. Argentina Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 32. Argentina Flow Cytometry, by End User USD Million (2013-2018)
  • Table 33. Rest of South America Flow Cytometry, by Type USD Million (2013-2018)
  • Table 34. Rest of South America Flow Cytometry, by Application USD Million (2013-2018)
  • Table 35. Rest of South America Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 36. Rest of South America Flow Cytometry, by End User USD Million (2013-2018)
  • Table 37. Asia Pacific Flow Cytometry, by Country USD Million (2013-2018)
  • Table 38. Asia Pacific Flow Cytometry, by Type USD Million (2013-2018)
  • Table 39. Asia Pacific Flow Cytometry, by Application USD Million (2013-2018)
  • Table 40. Asia Pacific Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 41. Asia Pacific Flow Cytometry, by End User USD Million (2013-2018)
  • Table 42. China Flow Cytometry, by Type USD Million (2013-2018)
  • Table 43. China Flow Cytometry, by Application USD Million (2013-2018)
  • Table 44. China Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 45. China Flow Cytometry, by End User USD Million (2013-2018)
  • Table 46. Japan Flow Cytometry, by Type USD Million (2013-2018)
  • Table 47. Japan Flow Cytometry, by Application USD Million (2013-2018)
  • Table 48. Japan Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 49. Japan Flow Cytometry, by End User USD Million (2013-2018)
  • Table 50. India Flow Cytometry, by Type USD Million (2013-2018)
  • Table 51. India Flow Cytometry, by Application USD Million (2013-2018)
  • Table 52. India Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 53. India Flow Cytometry, by End User USD Million (2013-2018)
  • Table 54. South Korea Flow Cytometry, by Type USD Million (2013-2018)
  • Table 55. South Korea Flow Cytometry, by Application USD Million (2013-2018)
  • Table 56. South Korea Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 57. South Korea Flow Cytometry, by End User USD Million (2013-2018)
  • Table 58. Taiwan Flow Cytometry, by Type USD Million (2013-2018)
  • Table 59. Taiwan Flow Cytometry, by Application USD Million (2013-2018)
  • Table 60. Taiwan Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 61. Taiwan Flow Cytometry, by End User USD Million (2013-2018)
  • Table 62. Australia Flow Cytometry, by Type USD Million (2013-2018)
  • Table 63. Australia Flow Cytometry, by Application USD Million (2013-2018)
  • Table 64. Australia Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 65. Australia Flow Cytometry, by End User USD Million (2013-2018)
  • Table 66. Rest of Asia-Pacific Flow Cytometry, by Type USD Million (2013-2018)
  • Table 67. Rest of Asia-Pacific Flow Cytometry, by Application USD Million (2013-2018)
  • Table 68. Rest of Asia-Pacific Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 69. Rest of Asia-Pacific Flow Cytometry, by End User USD Million (2013-2018)
  • Table 70. Europe Flow Cytometry, by Country USD Million (2013-2018)
  • Table 71. Europe Flow Cytometry, by Type USD Million (2013-2018)
  • Table 72. Europe Flow Cytometry, by Application USD Million (2013-2018)
  • Table 73. Europe Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 74. Europe Flow Cytometry, by End User USD Million (2013-2018)
  • Table 75. Germany Flow Cytometry, by Type USD Million (2013-2018)
  • Table 76. Germany Flow Cytometry, by Application USD Million (2013-2018)
  • Table 77. Germany Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 78. Germany Flow Cytometry, by End User USD Million (2013-2018)
  • Table 79. France Flow Cytometry, by Type USD Million (2013-2018)
  • Table 80. France Flow Cytometry, by Application USD Million (2013-2018)
  • Table 81. France Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 82. France Flow Cytometry, by End User USD Million (2013-2018)
  • Table 83. Italy Flow Cytometry, by Type USD Million (2013-2018)
  • Table 84. Italy Flow Cytometry, by Application USD Million (2013-2018)
  • Table 85. Italy Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 86. Italy Flow Cytometry, by End User USD Million (2013-2018)
  • Table 87. United Kingdom Flow Cytometry, by Type USD Million (2013-2018)
  • Table 88. United Kingdom Flow Cytometry, by Application USD Million (2013-2018)
  • Table 89. United Kingdom Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 90. United Kingdom Flow Cytometry, by End User USD Million (2013-2018)
  • Table 91. Netherlands Flow Cytometry, by Type USD Million (2013-2018)
  • Table 92. Netherlands Flow Cytometry, by Application USD Million (2013-2018)
  • Table 93. Netherlands Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 94. Netherlands Flow Cytometry, by End User USD Million (2013-2018)
  • Table 95. Rest of Europe Flow Cytometry, by Type USD Million (2013-2018)
  • Table 96. Rest of Europe Flow Cytometry, by Application USD Million (2013-2018)
  • Table 97. Rest of Europe Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 98. Rest of Europe Flow Cytometry, by End User USD Million (2013-2018)
  • Table 99. MEA Flow Cytometry, by Country USD Million (2013-2018)
  • Table 100. MEA Flow Cytometry, by Type USD Million (2013-2018)
  • Table 101. MEA Flow Cytometry, by Application USD Million (2013-2018)
  • Table 102. MEA Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 103. MEA Flow Cytometry, by End User USD Million (2013-2018)
  • Table 104. Middle East Flow Cytometry, by Type USD Million (2013-2018)
  • Table 105. Middle East Flow Cytometry, by Application USD Million (2013-2018)
  • Table 106. Middle East Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 107. Middle East Flow Cytometry, by End User USD Million (2013-2018)
  • Table 108. Africa Flow Cytometry, by Type USD Million (2013-2018)
  • Table 109. Africa Flow Cytometry, by Application USD Million (2013-2018)
  • Table 110. Africa Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 111. Africa Flow Cytometry, by End User USD Million (2013-2018)
  • Table 112. North America Flow Cytometry, by Country USD Million (2013-2018)
  • Table 113. North America Flow Cytometry, by Type USD Million (2013-2018)
  • Table 114. North America Flow Cytometry, by Application USD Million (2013-2018)
  • Table 115. North America Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 116. North America Flow Cytometry, by End User USD Million (2013-2018)
  • Table 117. United States Flow Cytometry, by Type USD Million (2013-2018)
  • Table 118. United States Flow Cytometry, by Application USD Million (2013-2018)
  • Table 119. United States Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 120. United States Flow Cytometry, by End User USD Million (2013-2018)
  • Table 121. Canada Flow Cytometry, by Type USD Million (2013-2018)
  • Table 122. Canada Flow Cytometry, by Application USD Million (2013-2018)
  • Table 123. Canada Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 124. Canada Flow Cytometry, by End User USD Million (2013-2018)
  • Table 125. Mexico Flow Cytometry, by Type USD Million (2013-2018)
  • Table 126. Mexico Flow Cytometry, by Application USD Million (2013-2018)
  • Table 127. Mexico Flow Cytometry, by Technology USD Million (2013-2018)
  • Table 128. Mexico Flow Cytometry, by End User USD Million (2013-2018)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Flow Cytometry: by Type(USD Million)
  • Table 140. Flow Cytometry Cytometry Platforms [Sorters, Analyzers] , by Region USD Million (2019-2024)
  • Table 141. Flow Cytometry Replaceable Components [Filter, Laser, Detectors, Others] , by Region USD Million (2019-2024)
  • Table 142. Flow Cytometry Accessories , by Region USD Million (2019-2024)
  • Table 143. Flow Cytometry Reagents and Consumables [Antibodies, Dyes, Beads, Solutions, Buffers, Others] , by Region USD Million (2019-2024)
  • Table 144. Flow Cytometry Software , by Region USD Million (2019-2024)
  • Table 145. Flow Cytometry Services , by Region USD Million (2019-2024)
  • Table 146. Flow Cytometry: by Application(USD Million)
  • Table 147. Flow Cytometry Academic and Clinical Research [Cell Cycle Analysis and Cell Proliferation, Apoptosis, Sorting and Screening, Transfection and Cell Viability, Others] , by Region USD Million (2019-2024)
  • Table 148. Flow Cytometry Diagnosis [Organ Transplantation, Hematological Malignancies, Cancer and Solid Tumors, Immunodeficiency Diseases- HIV Infection, Others] , by Region USD Million (2019-2024)
  • Table 149. Flow Cytometry: by Technology(USD Million)
  • Table 150. Flow Cytometry Cell-Based , by Region USD Million (2019-2024)
  • Table 151. Flow Cytometry Bead-Based , by Region USD Million (2019-2024)
  • Table 152. Flow Cytometry: by End User(USD Million)
  • Table 153. Flow Cytometry Commercial Organizations , by Region USD Million (2019-2024)
  • Table 154. Flow Cytometry Medical Schools and Clinical Labs , by Region USD Million (2019-2024)
  • Table 155. Flow Cytometry Hospitals , by Region USD Million (2019-2024)
  • Table 156. Flow Cytometry Academics , by Region USD Million (2019-2024)
  • Table 157. Flow Cytometry Others , by Region USD Million (2019-2024)
  • Table 158. South America Flow Cytometry, by Country USD Million (2019-2024)
  • Table 159. South America Flow Cytometry, by Type USD Million (2019-2024)
  • Table 160. South America Flow Cytometry, by Application USD Million (2019-2024)
  • Table 161. South America Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 162. South America Flow Cytometry, by End User USD Million (2019-2024)
  • Table 163. Brazil Flow Cytometry, by Type USD Million (2019-2024)
  • Table 164. Brazil Flow Cytometry, by Application USD Million (2019-2024)
  • Table 165. Brazil Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 166. Brazil Flow Cytometry, by End User USD Million (2019-2024)
  • Table 167. Argentina Flow Cytometry, by Type USD Million (2019-2024)
  • Table 168. Argentina Flow Cytometry, by Application USD Million (2019-2024)
  • Table 169. Argentina Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 170. Argentina Flow Cytometry, by End User USD Million (2019-2024)
  • Table 171. Rest of South America Flow Cytometry, by Type USD Million (2019-2024)
  • Table 172. Rest of South America Flow Cytometry, by Application USD Million (2019-2024)
  • Table 173. Rest of South America Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 174. Rest of South America Flow Cytometry, by End User USD Million (2019-2024)
  • Table 175. Asia Pacific Flow Cytometry, by Country USD Million (2019-2024)
  • Table 176. Asia Pacific Flow Cytometry, by Type USD Million (2019-2024)
  • Table 177. Asia Pacific Flow Cytometry, by Application USD Million (2019-2024)
  • Table 178. Asia Pacific Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 179. Asia Pacific Flow Cytometry, by End User USD Million (2019-2024)
  • Table 180. China Flow Cytometry, by Type USD Million (2019-2024)
  • Table 181. China Flow Cytometry, by Application USD Million (2019-2024)
  • Table 182. China Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 183. China Flow Cytometry, by End User USD Million (2019-2024)
  • Table 184. Japan Flow Cytometry, by Type USD Million (2019-2024)
  • Table 185. Japan Flow Cytometry, by Application USD Million (2019-2024)
  • Table 186. Japan Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 187. Japan Flow Cytometry, by End User USD Million (2019-2024)
  • Table 188. India Flow Cytometry, by Type USD Million (2019-2024)
  • Table 189. India Flow Cytometry, by Application USD Million (2019-2024)
  • Table 190. India Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 191. India Flow Cytometry, by End User USD Million (2019-2024)
  • Table 192. South Korea Flow Cytometry, by Type USD Million (2019-2024)
  • Table 193. South Korea Flow Cytometry, by Application USD Million (2019-2024)
  • Table 194. South Korea Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 195. South Korea Flow Cytometry, by End User USD Million (2019-2024)
  • Table 196. Taiwan Flow Cytometry, by Type USD Million (2019-2024)
  • Table 197. Taiwan Flow Cytometry, by Application USD Million (2019-2024)
  • Table 198. Taiwan Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 199. Taiwan Flow Cytometry, by End User USD Million (2019-2024)
  • Table 200. Australia Flow Cytometry, by Type USD Million (2019-2024)
  • Table 201. Australia Flow Cytometry, by Application USD Million (2019-2024)
  • Table 202. Australia Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 203. Australia Flow Cytometry, by End User USD Million (2019-2024)
  • Table 204. Rest of Asia-Pacific Flow Cytometry, by Type USD Million (2019-2024)
  • Table 205. Rest of Asia-Pacific Flow Cytometry, by Application USD Million (2019-2024)
  • Table 206. Rest of Asia-Pacific Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 207. Rest of Asia-Pacific Flow Cytometry, by End User USD Million (2019-2024)
  • Table 208. Europe Flow Cytometry, by Country USD Million (2019-2024)
  • Table 209. Europe Flow Cytometry, by Type USD Million (2019-2024)
  • Table 210. Europe Flow Cytometry, by Application USD Million (2019-2024)
  • Table 211. Europe Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 212. Europe Flow Cytometry, by End User USD Million (2019-2024)
  • Table 213. Germany Flow Cytometry, by Type USD Million (2019-2024)
  • Table 214. Germany Flow Cytometry, by Application USD Million (2019-2024)
  • Table 215. Germany Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 216. Germany Flow Cytometry, by End User USD Million (2019-2024)
  • Table 217. France Flow Cytometry, by Type USD Million (2019-2024)
  • Table 218. France Flow Cytometry, by Application USD Million (2019-2024)
  • Table 219. France Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 220. France Flow Cytometry, by End User USD Million (2019-2024)
  • Table 221. Italy Flow Cytometry, by Type USD Million (2019-2024)
  • Table 222. Italy Flow Cytometry, by Application USD Million (2019-2024)
  • Table 223. Italy Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 224. Italy Flow Cytometry, by End User USD Million (2019-2024)
  • Table 225. United Kingdom Flow Cytometry, by Type USD Million (2019-2024)
  • Table 226. United Kingdom Flow Cytometry, by Application USD Million (2019-2024)
  • Table 227. United Kingdom Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 228. United Kingdom Flow Cytometry, by End User USD Million (2019-2024)
  • Table 229. Netherlands Flow Cytometry, by Type USD Million (2019-2024)
  • Table 230. Netherlands Flow Cytometry, by Application USD Million (2019-2024)
  • Table 231. Netherlands Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 232. Netherlands Flow Cytometry, by End User USD Million (2019-2024)
  • Table 233. Rest of Europe Flow Cytometry, by Type USD Million (2019-2024)
  • Table 234. Rest of Europe Flow Cytometry, by Application USD Million (2019-2024)
  • Table 235. Rest of Europe Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 236. Rest of Europe Flow Cytometry, by End User USD Million (2019-2024)
  • Table 237. MEA Flow Cytometry, by Country USD Million (2019-2024)
  • Table 238. MEA Flow Cytometry, by Type USD Million (2019-2024)
  • Table 239. MEA Flow Cytometry, by Application USD Million (2019-2024)
  • Table 240. MEA Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 241. MEA Flow Cytometry, by End User USD Million (2019-2024)
  • Table 242. Middle East Flow Cytometry, by Type USD Million (2019-2024)
  • Table 243. Middle East Flow Cytometry, by Application USD Million (2019-2024)
  • Table 244. Middle East Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 245. Middle East Flow Cytometry, by End User USD Million (2019-2024)
  • Table 246. Africa Flow Cytometry, by Type USD Million (2019-2024)
  • Table 247. Africa Flow Cytometry, by Application USD Million (2019-2024)
  • Table 248. Africa Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 249. Africa Flow Cytometry, by End User USD Million (2019-2024)
  • Table 250. North America Flow Cytometry, by Country USD Million (2019-2024)
  • Table 251. North America Flow Cytometry, by Type USD Million (2019-2024)
  • Table 252. North America Flow Cytometry, by Application USD Million (2019-2024)
  • Table 253. North America Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 254. North America Flow Cytometry, by End User USD Million (2019-2024)
  • Table 255. United States Flow Cytometry, by Type USD Million (2019-2024)
  • Table 256. United States Flow Cytometry, by Application USD Million (2019-2024)
  • Table 257. United States Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 258. United States Flow Cytometry, by End User USD Million (2019-2024)
  • Table 259. Canada Flow Cytometry, by Type USD Million (2019-2024)
  • Table 260. Canada Flow Cytometry, by Application USD Million (2019-2024)
  • Table 261. Canada Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 262. Canada Flow Cytometry, by End User USD Million (2019-2024)
  • Table 263. Mexico Flow Cytometry, by Type USD Million (2019-2024)
  • Table 264. Mexico Flow Cytometry, by Application USD Million (2019-2024)
  • Table 265. Mexico Flow Cytometry, by Technology USD Million (2019-2024)
  • Table 266. Mexico Flow Cytometry, by End User USD Million (2019-2024)
  • Table 267. Research Programs/Design for This Report
  • Table 268. Key Data Information from Secondary Sources
  • Table 269. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Flow Cytometry: by Type USD Million (2013-2018)
  • Figure 5. Global Flow Cytometry: by Application USD Million (2013-2018)
  • Figure 6. Global Flow Cytometry: by Technology USD Million (2013-2018)
  • Figure 7. Global Flow Cytometry: by End User USD Million (2013-2018)
  • Figure 8. South America Flow Cytometry Share (%), by Country
  • Figure 9. Asia Pacific Flow Cytometry Share (%), by Country
  • Figure 10. Europe Flow Cytometry Share (%), by Country
  • Figure 11. MEA Flow Cytometry Share (%), by Country
  • Figure 12. North America Flow Cytometry Share (%), by Country
  • Figure 13. Global Flow Cytometry share by Players 2018 (%)
  • Figure 14. Global Flow Cytometry share by Players (Top 3) 2018(%)
  • Figure 15. Global Flow Cytometry share by Players (Top 5) 2018(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 18. Becton, Dickinson and Company (United States) Revenue: by Geography 2018
  • Figure 19. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2018
  • Figure 21. Beckman Coulter, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Beckman Coulter, Inc. (United States) Revenue: by Geography 2018
  • Figure 23. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Merck KGaA (Germany) Revenue: by Geography 2018
  • Figure 25. Luminex Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 26. Luminex Corporation (United States) Revenue: by Geography 2018
  • Figure 27. Sysmex Partec GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Sysmex Partec GmbH (Germany) Revenue: by Geography 2018
  • Figure 29. Miltenyi Biotec GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Miltenyi Biotec GmbH (Germany) Revenue: by Geography 2018
  • Figure 31. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Agilent Technologies, Inc. (United States) Revenue: by Geography 2018
  • Figure 33. BioMérieux S.A. (France) Revenue, Net Income and Gross profit
  • Figure 34. BioMérieux S.A. (France) Revenue: by Geography 2018
  • Figure 35. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2018
  • Figure 37. Global Flow Cytometry: by Type USD Million (2019-2024)
  • Figure 38. Global Flow Cytometry: by Application USD Million (2019-2024)
  • Figure 39. Global Flow Cytometry: by Technology USD Million (2019-2024)
  • Figure 40. Global Flow Cytometry: by End User USD Million (2019-2024)
  • Figure 41. South America Flow Cytometry Share (%), by Country
  • Figure 42. Asia Pacific Flow Cytometry Share (%), by Country
  • Figure 43. Europe Flow Cytometry Share (%), by Country
  • Figure 44. MEA Flow Cytometry Share (%), by Country
  • Figure 45. North America Flow Cytometry Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Becton, Dickinson and Company (United States)
  • Thermo Fisher Scientific, Inc. (United States)
  • Beckman Coulter, Inc. (United States)
  • Merck KGaA (Germany)
  • Luminex Corporation (United States)
  • Sysmex Partec GmbH (Germany)
  • Miltenyi Biotec GmbH (Germany)
  • Agilent Technologies, Inc. (United States)
  • bioMérieux S.A. (France)
  • Bio-Rad Laboratories, Inc. (United States)
Additional players considered in the study are as follows:
Sony Biotechnology, Inc. (United States) , Enzo Life Sciences, Inc. (United States) , Stratedigm, Inc. (United States) , Cytonome/ST LLC (United States) , Apogee Flow Systems Ltd. (United Kingdom)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation